Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies.

FDA clears Medtronic’s new smart diabetes management app
Medtronic's MiniMed Go technology was designed to deliver real-time health data and recommendations to patients with type 1 and type 2 diabetes. It works with the Instinct sensors designed by Abbott.
‘Mental clarity’ supplement recalled due to risk of cardiovascular events, suicidal thoughts
This product was distributed throughout the United States from April 2022 to December 2025. Customers have been warned to stop taking it immediately.
Medicaid cuts under ‘One Big Beautiful Bill’ could result in over 1 million missed cancer screenings
Over the first two years of implementation, about 7.5 million Medicaid enrollees eligible for cancer screenings will lose coverage, researchers estimate.
FDA recalls organ recovery kits due to low-grade plastic bags
The recall has been designated a Class I, the most serious type. Certain "convenience kits" manufactured by AVID Medical contain non–medical-grade bags that could expose organs to toxins, increasing the odds of a transplant recipient's body rejecting them.
House passes ACA extension as Senate also considers competing GOP-backed act
Seventeen Republicans joined Democrats to pass a three-year extension to the tax credits that made medical plans sold through HealthCare.gov cheaper for millions of Americans. However, the GOP passed a competing measure in December that would see the federal government focus on association health plans. It’s unclear if either will find traction in the Senate.

Medtronic has received U.S. Food and Drug Administration (FDA) clearance for the MiniMed Go Smart Multiple Daily Injection system.

FDA clears Medtronic’s new smart diabetes management app

Medtronic's MiniMed Go technology was designed to deliver real-time health data and recommendations to patients with type 1 and type 2 diabetes. It works with the Instinct sensors designed by Abbott.

The U.S. Food and Drug Administration (FDA) has announced that Modern Warrior is recalling all lots of its Modern Warrior Ready capsules, a dietary supplement marketed as a way to boost metabolism, improve brain function and reduce cravings.

‘Mental clarity’ supplement recalled due to risk of cardiovascular events, suicidal thoughts

This product was distributed throughout the United States from April 2022 to December 2025. Customers have been warned to stop taking it immediately.

Medicaid cuts under ‘One Big Beautiful Bill’ could result in over 1 million missed cancer screenings

Over the first two years of implementation, about 7.5 million Medicaid enrollees eligible for cancer screenings will lose coverage, researchers estimate.

warning safety alert recall healthcare issue

FDA recalls organ recovery kits due to low-grade plastic bags

The recall has been designated a Class I, the most serious type. Certain "convenience kits" manufactured by AVID Medical contain non–medical-grade bags that could expose organs to toxins, increasing the odds of a transplant recipient's body rejecting them.

House passes ACA extension as Senate also considers competing GOP-backed act

Seventeen Republicans joined Democrats to pass a three-year extension to the tax credits that made medical plans sold through HealthCare.gov cheaper for millions of Americans. However, the GOP passed a competing measure in December that would see the federal government focus on association health plans. It’s unclear if either will find traction in the Senate.

3 high-level briefings: Healthcare is an employment anomaly | Nurses are burning out | Dr. Birx is bullish on health data

The latest federal jobs report brings good news to healthcare and social assistance, bad news to most other sectors.

FDA announces supplement recall over risk of heart attack or stroke

Silintan is a dietary supplement marketed as a treatment for joint and body aches. According to a recent analysis by the FDA, however, all lots contained undeclared meloxicam, creating an increased risk of adverse events.

Nirat Beohar, MD, director, cardiac catheterization laboratory, medical director of the structural heart disease program, Mount Sinai Medical Center in Miami Beach, Florida, and a professor at the Columbia University Division of Cardiology, explains the financial landscape of the cath lab, what is ahead, and why cardiologists need to become more business savvy. #TCT

The business of cardiology is changing—and cath labs are working to keep up

Financial literacy is no longer optional for physicians. “If you're not financially viable, you can't function,” explained Nirat Beohar, MD. “The business education is probably just as important as learning a new procedure.”